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We retrospectively evaluated the safety and eﬃcacy of artiﬁcial pneumothorax induction to perform 
computed tomography (CT)-guided radiofrequency ablation (RFA) for sub-diaphragm hepatocellular 
carcinomas (HCCs).  From June 2008 to October 2010 at our institution,  19 HCCs (16 patients) were 
treated using CT-guided RFA after artiﬁcial pneumothorax induction.  A 23-G needle was inserted into 
the liver surface at a site of 2 connected pleurae without lung tissue.  After a small amount of air was 
injected,  the pleural space widened,  creating a small pneumothorax.  Additional air was insuﬄated via 
a newly inserted 18-G cannula to raise the lung away from the planned puncture line for RFA.  The 
electrode was then advanced transthoracically.  Ablation was performed using a cool-tip electrode with 
manual impedance control mode.  The injected air was then aspirated as much as possible.  Artiﬁcial 
pneumothorax was successfully induced in all cases.  The average total volume of injected air in each 
case was 238ml.  No artiﬁcial pneumothorax-related complication occurred; lung injury occurred in one 
case during RF electrode insertion.  No local progression occurred during follow-up.  Recurring HCCs 
were observed in eight patients.  Artiﬁcial pneumothorax induction is safe and eﬀective for CT-guided 
RFA of sub-diaphragm HCCs,  which are diﬃcult to locate on US.
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L iver radiofrequency ablation (RFA) is widely accepted as a successful,  locally controlled 
treatment for hepatocellular carcinoma (HCC).  RFA 
is usually performed under ultrasonography (US) guid-
ance.  However,  US is not always eﬀective; an 
example is its sometimes-inadequate detection of sub-
diaphragm HCCs.  RFA for subphrenic HCC has 
proven diﬃcult to perform successfully because of the 
reported risks of local progression following the pro-
cedure [1,  2].  Many novel techniques have been 
developed to improve the eﬃcacy of RFA for sub-
phrenic HCC.  Some of the methods being investigated 
are artiﬁcial pleural eﬀusion,  artiﬁcial ascites,  a 
trans-thoracic approach under computed tomography 
(CT) guidance,  and thoracoscopic or laparoscopic 
approaches [3-11].  Generally,  the choice of treat-
ment method depends on the preference of the medical 
professional or the institution according to,  for 
example,  the ease and availability of CT or general 
anesthesia.
　 In the case of CT-guided RFA,  the use of artiﬁcial 
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pleural eﬀusion is challenging because it depends on 
the patientʼs body position during the procedure.  The 
transthoracic approach with lung penetration fre-
quently results in a pneumothorax [7-9] and may even 
cause an air embolism [12-14].  To minimize complica-
tions following the procedure,  we have performed 
CT-guided liver RFA after inducing an artiﬁcial 
pneumothorax.  The purpose of the present study was 
to retrospectively evaluate the safety and eﬃcacy of 
the artiﬁcial pneumothorax induced during liver RFA.
Patients and Methods
　 From June 2008 to October 2010,  32 patients 
were treated at our institution using CT-guided liver 
RFA,  because of the restricted eﬃcacy of US for the 
detection of sub-diaphragm HCCs.  Of these patients,  
19 HCCs in 16 patients were treated using CT-guided 
RFA with an induced artiﬁcial pneumothorax.  An 
artiﬁcial pneumothorax was induced when the lung was 
on the puncture line.  The patient characteristics are 
summarized in Table 1.  The locations of the HCCs 
treated using CT-guided RFA were as follows:  
segment 1 for two HCCs,  segment 4 for three HCCs,  
segment 7 for ﬁve HCCs,  and segment 8 for nine 
HCCs.  The median diameter of the HCCs was 16mm 
(range 10-44mm).  Overt pleural adhesion was consid-
ered a contraindication in the patients with a history 
of lung surgery,  chronic lung inﬂammation,  or 
pleurodesis because in such cases,  it might not be 
possible to induce an artiﬁcial pneumothorax.
　 If the tumor was not visible by plain CT,  transar-
terial chemoembolization was performed several days 
before the liver RFA in conventional fashion using 
lipiodol.  Lipiodol accumulation inside the HCC was 
helpful to achieve accurate penetration under CT ﬂuo-
roscopic guidance.  The body position of the patient 
during the procedure depended on the tumor location,  
in order to successfully raise the base of the lung 
using an artiﬁcial pneumothorax.  The supine position 
was chosen when the tumor was located in the anterior 
segment; the prone position when the tumor was in the 
posterior segment,  and the lateral decubitus position 
when the tumor was on the lateral side of the liver.
　 Artiﬁcial pneumothorax was introduced in 2 steps.  
First,  a 23-G needle was inserted under CT ﬂuoro-
scopic guidance into the liver surface at a location of 
two connected pleurae,  where no lung tissue was 
present.  If the needle tip was located in the thoracic 
space,  a small amount of air (20-100ml) could sepa-














1. 76M 4 supine 15 100 no 28
2. 62M 8 supine 17 200 no 25
3. 77M 8 supine 15 30 no 22
4. 74F 8 supine 18 200 no 21
5. 76F 8 supine 15 150 no 19
6. 61M 8 supine 22 50 no 18
7. 72F 8 supine 12 150 no 17
7.  8 supine 10
7. ＊ 8 supine 12 250 no 9
8. 83M 4 supine 11 300 no 10
9. 67M 8 supine 16 250 no 7
10. 74M 8 lateral 16 300 no 7
11. 76M 8 supine 16 200 no 7
12. 62M 7 lateral 36 400 no 6
12.  1 lateral 18 ＊＊lung injury
13. 63F 1 prone 44 400 4
14. 70M 7 prone 11 120 no 4
15. 78F 7 prone 20 200 no 3
16. 31M 7 supine 17 600 no 3
＊Patient 7 underwent RFA twice.  Two HCCs were treated at ﬁrst ablation.
＊＊A lung injury occurred during the RF electrode insertion.
rate the contacting pleurae,  creating the small artiﬁ-
cially induced pneumothorax.  Next,  an 18-G cannula 
(Surﬂo; Terumo,  Tokyo,  Japan) with a side hole was 
introduced into this space.  Additional air was insuf-
ﬂated until the base of the lung was raised above the 
planned puncture route for the RFA (Fig.  1).  The 
electrode was then inserted transthoracically,  without 
penetrating the lung.  After liver ablation,  the injected 
air was aspirated as much as possible.
　 RFA was performed under local anesthesia,  using 
a Cool-tipTM electrode (Valleylab,  Boulder,  CO,  USA).  
In all cases,  the insertion of the electrode was per-
formed using CT ﬂuoroscopic guidance (Somatom 
Sensation-16 scanner; Siemens Medical Systems,  
Erlangen,  Germany).  The conditions of the CT ﬂuo-
roscopy were 100kV and 30mAs.  After the insertion 
of the electrode,  a 1-mm collimation CT scan was 
obtained.  The electrode position was characterized in 
three directions: axial,  coronal,  and sagittal.  The RF 
energy was applied using an impedance-controlled 
algorithm.  The puncture tract was ablated following 
the removal of the electrode,  and a chest radiogram 
was obtained 2h after the procedure and then again the 
next morning to check for the presence of a pneumo-
thorax.  Local progression or the development of new 
HCCs was monitored using CT or magnetic resonance 
imaging (MRI) every 3 months after the procedure.  
Our institutional review board permitted this retro-
spective study.
Results
　 The artiﬁcial pneumothorax was successfully 
induced in all 16 patients.  Pleural adhesion was not 
observed in any of the patients.  The median injected 
air volume was 200ml (range 30-600ml).  Following 
the induction of the artiﬁcial pneumothorax,  no com-
plications,  such as a decrease of blood oxygen satura-
tion or hemorrhage,  were recorded.  At the end of 
each procedure,  almost all of the injected air was 
successfully aspirated through the 18-G cannula with 
a side hole.
　 The procedure was performed in the supine posi-
tion in 11 patients (64.7 ),  in the lateral position in 
3 patients (17.6 ),  and in the prone position in 3 
patients (17.6 ).  In one patients,  RFA with the 
artiﬁcial pneumothorax was performed twice to treat 
a second,  newly developed HCC.  Each artiﬁcial 
pneumothorax was successfully induced (twice in the 
same patient),  and no pleural adhesion was observed.
　 In all cases,  the RFA was completed transthoraci-
cally without penetrating the lung.  In 14 cases 
(82.4 ),  the lung was moved away successfully from 
the puncture root on the axial CT view (Fig.  2).  In 3 
cases (17.6 ),  the base of the lung did not move away 
fully.  In this instance,  the puncture site was shifted 
to the caudal side.  The electrode was then inserted 
below the base of the lung in order to avoid lung pen-
etration,  and the RFA was completed successfully 
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Fig. 1　 The method used to induce an artiﬁcial pneumothorax.  A,  White dots are puncture guides placed on the body surface.  The 
puncture point is near the cost phrenic angle,  where no lung tissue is present; B,  After local anesthesia is administered using a 23-G 
needle,  and a small amount of air is injected from the same needle.  If the needle tip catches the thoracic cavity,  injected air spreads into 
the thorax; C,  A small artiﬁcial pneumothorax can be induced following an injection of 20-100ml of air.  An 18-G cannula is then intro-
duced under CT ﬂuoroscopic guidance.  Additional air is injected until the base of the lung is raised above the level of the tumor.
(Fig.  3).  Among these three tumors,  which were 
located in segment 7 or 1,  lung damage occurred in 
one case during the electrode insertion.  A long RF 
electrode (20cm) was used because the tumor was 
deeply located.  In this case,  the electrode could not 
be inserted under CT ﬂuoroscopic guidance because of 
the narrow gantry space and the lateral position of the 
patient.  A 20-cm-long electrode was used only in this 
case.  By the time the electrode tip had been observed 
using CT ﬂuoroscopy,  the electrode had already 
injured the base of the lung.  The puncture site was 
moved further to the caudal side,  and the RFA was 
completed without penetrating the lung.  A small 
pneumothorax occurred after the procedure but did not 
require chest tube placement.  Other complications 
such as hemorrhage or infection were not observed.
　 Follow-up CT or MRI examinations were performed 
periodically,  with a median follow-up period of 9.5 
months (range 3-28 months).  Local progression did not 
occur,  but the development of new HCCs was reported 
in eight patients (50 ).
Discussion
　 Liver RFA is usually performed under US guid-
ance because of its convenience.  However,  US cannot 
always locate HCCs,  particularly sub-diaphragm HCCs.  
New methods are required to increase the success rate 
of these procedures.  Artiﬁcial pleural eﬀusion has 
been reported to be a useful method [3,  4],  in which 
a 5  glucose sterile solution is injected into the pleu-
ral cavity using a Veress needle (a blunt-tipped needle) 
with the patient in a semi-sitting position until the 
tumor is located.  This method is useful to treat 
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Fig. 2　 The patient was a 60-year-old woman.  Local progression occurred at the site after the transarterial embolization of the HCC.  A,  
The recurrent HCC is shown in segment 8,  located just below the diaphragm.  Lipiodol accumulation was observed on the ventral side of 
the recurrent tumor; B,  After the induction of the artiﬁcial pneumothorax,  a 17-G cool-tip electrode was introduced through the thoracic 
cavity without penetrating the lung tissue; C,  This ﬁgure illustrates the sagittal reconstruction along the electrode.  The lung tissue is raised 
above the diaphragm; D,  Contrast-enhanced CT was performed the day after the RFA.  The recurrent tumor was fully ablated using RFA.
obscured subphrenic HCCs,  but is not performed in 
every institution.
　 Another method was also reported: CT-guided 
RFA with lung penetration.  This method resulted in 
frequent pneumothoraces (38-71  of cases).  In 0-29  
of the procedures performed in this manner,  chest 
tube placement is required [7-9].  Double penetration 
of the visceral pleurae can frequently cause complica-
tions,  and lung penetration may cause an air embolism.  
The frequency of air embolism has been reported to be 
0.07  [12] and more recently,  0.4  [13].  If possi-
ble,  avoidance of lung penetration is preferred,  
because there is no eﬀective way of protecting against 
an air embolism,  which can sometimes be fatal [14].
　 Thoracoscopy- or laparoscopy-assisted liver RFA 
is a more invasive procedure,  requiring general anes-
thesia [10,  11].  At our institute,  CT can be conve-
niently used to guide interventional procedures.  We 
thus consider the use of CT-guided liver RFA with an 
induced artiﬁcial pneumothorax a less invasive option 
in the treatment of HCCs previously undetected on 
US.
　 Air can be introduced into the thorax in several 
ways.  A blunt-tipped needle is advanced to the lung to 
penetrate the thoracic cavity [15].  However,  even a 
blunt-tipped needle can lead to lung damage in cases of 
pleural adhesion.  On the other hand,  our method uses 
a needle puncture at the bottom of the thoracic cavity 
where no lung tissue exists,  in order to prevent lung 
injury.  CT cannot visualize the thoracic cavity at the 
level of the liver surface,  but the thoracic cavity can 
be punctured by advancing the needle tip to the sur-
face of the diaphragm.  If the needle tip is positioned 
inside the thorax,  injected air spreads into the thorax 
and separates the 2 parietal pleurae,  which can then 
be detected using CT.  If the needle tip is positioned 
outside the thorax,  injected air remains near the 
needle tip.  If the needle tip is positioned inside the 
abdominal cavity,  injected air spreads along the liver 
surface.  The thoracic cavity can be observed following 
the adjustment of the needle tip under CT ﬂuoro-
scopic guidance.
　 After the induction of a small artiﬁcial pneumotho-
rax,  another 18-G cannula with side hole is advanced 
into the thorax.  Additional air is injected thorough the 
coaxial needle until the lung tissue is raised above the 
tumor level.  An injection of 400ml of air can elevate 
the lung in 82  of cases in this study.  As the width of 
the lung is thinner at the bottom of the thoracic cavity,  
the base of the lung can be raised by a small volume of 
air injection.  However,  injected air gradually spreads 
upward,  and the lung is not lifted even if the volume 
of injected air has increased.  Therefore,  the injection 
of air is discontinued after approx.  500ml of air,  and 
the insertion of the electrode is performed from a 
lower level to prevent lung injury.  Insertion of the 
electrode was completed in all of the present cases,  
but pneumothorax occurred in only one patient during 
the electrode insertion,  in which suﬃcient elevation of 
the lower lobe was not obtained.  It might be diﬃcult 
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Fig. 3　 The patient was a 65-year-old man.  Transarterial chemoembolization was performed before the RFA,  because the tumor was not 
visible on plain CT.  Lipiodol had strongly accumulated in the tumor after the chemoembolization.  A,  RFA was performed in the lateral 
position,  because the electrode was introduced laterally to avoid penetration of the right hepatic vein or portal tract in segment 8.  Despite 
the injection of 300ml of air into the thorax,  the lung did not move away from the puncture line; B,  Because the injected air spread to the 
cranial side,  the air injection was stopped and the electrode was re-introduced from the caudal side.  The electrode was introduced into the 
center of the tumor without penetrating the lung.
to lift the lower lobe suﬃciently because the volume of 
lung parenchyma is higher in the lower lobe.
　 Injected air can spread into the independent portion 
in the thorax,  and thus the patient position strongly 
aﬀects the distribution of the injected air.  In the pres-
ent patient series,  the position of the patient during 
the procedure was determined according to the tumor 
location; if the tumor was in segment 4,  the patient 
was in the supine position.  If the tumor was in seg-
ment 7,  the patient was in the prone position.
　 Our convenient and low-cost method for inducing an 
artiﬁcial pneumothorax does not require any special 
equipment,  such as a needle with a protective sheath.  
Injected air can be aspirated following the RFA pro-
cedure via an 18-G cannula with a side hole.  If a side 
hole is not present,  the needle tip can easily be 
obstructed so that injected air cannot be aspirated 
suﬃciently.
　 We conducted a literature review by searching the 
PubMed database.  The search was performed using 
the keywords “liver” and “radiofrequency ablation” and 
“pneumothorax”.  For the years from 2001 to 2015,  
there is only one report of liver RFA with the induc-
tion of an artiﬁcial pneumothorax [16].  In that report,  
the artiﬁcial pneumothorax was induced using an epi-
dural kit.  The needle was injected by applying positive 
pressure using a syringe plunger.  When the needle tip 
was inside the thoracic cavity,  the syringe pressure 
decreased.  The induction of an artiﬁcial pneumotho-
rax was successful in all cases,  without complications.  
However,  a needle insertion toward the lung may 
cause lung injury.  Our way of introducing an artiﬁcial 
pneumothorax may be safer because we puncture the 
thoracic cavity at the bottom where no lung tissue 
exists.  In the present study,  the mean injected air 
volume was 566ml (range 200-800ml).  The injected 
air volume and the treatment eﬀects of RFA were 
similar to those in our cases.
　 An artiﬁcial pneumothorax is used in other proce-
dures such as lung RFA and mediastinal tumor biop-
sies [15,  17,  18].  In those studies,  an artiﬁcial pneu-
mothorax could not be induced in 2 cases because of 
pleural adhesion.  A history of thoracic surgery or 
radiation therapy is an obstacle for the induction of an 
artiﬁcial pneumothorax.  Solomon et al.  reported that 
750ml of air injected into the thoracic cavity caused a 
decrease in saturated oxygenation [15].  In contrast,  
2,000ml of injected air did not cause any complica-
tions during a mediastinal biopsy [17,  18].  The air 
injection should be performed carefully,  paying special 
attention to the risk of dyspnea or circulatory changes.  
Unlike mediastinal biopsies,  liver RFAs can be per-
formed with smaller volumes of injected air,  because 
the lung tissue can easily be raised above the level of 
the thoracic base.
　 We observed that,  by our method,  subphrenic 
HCCs were well controlled using RFA,  and local 
progression was not reported during the follow-up 
period.  Therefore,  sub-diaphragm HCCs can be suc-
cessfully treated with a low complication rate by 
inducing an artiﬁcial pneumothorax.  However,  we 
observed that newly developed HCCs did occur in 
other parts of the liver in half of the cases in the 
present study.
　 We should also highlight the potential limitations 
of the present study.  First,  the patient population 
was small (n＝16).  Because pleural adhesion cannot 
be judged clearly before the procedure,  artiﬁcial 
pneumothoraces may not be induced in some cases.  In 
addition,  this study was retrospective.  Prospective 
clinical studies are needed to further evaluate the 
usefulness of this procedure.
　 In conclusion,  subphrenic HCCs can be treated 
eﬀectively using CT-guided liver RFA by inducing an 
artiﬁcial pneumothorax.  Artiﬁcial pneumothoraces 
were induced in all cases without complications.  The 
induction of an artiﬁcial pneumothorax is a safe and 
eﬀective method to minimize the complications of 
CT-guided liver RFA to treat subphrenic HCCs.
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